Presentation Information
[P2-16]Legal issues surrounding controlled human infection model (CHIM) trials for vaccine development
*Waki Toya1, Masahiro Kitao2, Yusuke Inoue3, Kaori Muto1 (1. The Institute of Medical Science, The University of Tokyo (Japan), 2. Institute of Business Sciences, University of Tsukuba (Japan), 3. School of Public Health, Kyoto University (Japan))
Keywords:
Japanese Law and Legislation,CHIM (controlled human infection model),Quarantine,Isolation
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
